Stay updated on CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page
- Check5 days agoChange DetectedFooter updates include the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Publications section adds a note that publications are provided voluntarily by the entrant and pertain to study results, and the revision label changes from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check41 days agoChange DetectedDeleted the administrative funding/operating status notice banner from the page. Core study information such as the title, conditions, interventions, eligibility criteria, and outcomes remains unchanged.SummaryDifference0.4%

- Check56 days agoChange DetectedThe updates appear to be administrative in nature, including revised last update dates and minor formatting/text edits; no changes to the core trial content (arms, eligibility, or outcomes) were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference2%

- Check91 days agoChange DetectedTerm naming updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.